Delova Biotech
Qixia
About Delova Biotech
Delova Biotech specializes in the field of pain treatment. It uses the company's rich R&D experience and special preparation technology platform to improve existing drugs and conduct research and development of improved new analgesics in China and the United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $21.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2024)
- Website: delovabio.com
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/delova-biotech-101016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.